Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
No LD50 (lethal dose) has been established because researchers have not been able to achieve lethal toxicity in test animals
PMID: 20225319
Dual-peptide research advantage Combining BPC-157 and TB-500 in a single vial allows researchers to simplify preparation and maintain consistency across experimental workflows
The FDAs current safety page continues to cite concerns about immunogenicity, peptide impurities and limited safety data, and the agency has stated that a substance may still pose significant safety risks
The 2 mL option is the default assumption used throughout this page
Indsigt i vrdibaseret ledelse, som sikrer, at dine beslutninger afspejler organisationens kernevrdier
US$ 23.18
US$ 23.07
US$ 26.61
US$ 25.74
US$ 20.52
US$ 28.50
US$ 26.83
US$ 20.78
